<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00755131</url>
  </required_header>
  <id_info>
    <org_study_id>UNINA-15775</org_study_id>
    <nct_id>NCT00755131</nct_id>
  </id_info>
  <brief_title>Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction</brief_title>
  <official_title>Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This purpose of this study is to examine the relationship between HMGB-1 and postinfarction
      predictors of outcome such as cardiopulmonary and echocardiographic parameters before and
      after a 6-month exercise-based cardiac rehabilitation program.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Exercise-based Cardiac Rehabilitation after acute myocardial infarction (AMI) has beneficial
      effects on cardiovascular functional capacity, quality of life, risk factors modification,
      and morbidity and mortality. Mounting evidences suggest that inflammation plays a key role
      both on initiation and progression of atherosclerosis. Several markers of systemic
      inflammation appear to be active effectors in the pathophysiology of athero-thrombotic
      disease leading to the occurrence of AMI.

      The high mobility group box 1 (HMGB-1) is a ubiquitous nuclear protein constitutively
      expressed in quiescent cells, and it has been implicated in several cellular functions,
      including determination of nucleosomal structure and stability, and binding of transcription
      factors to DNA sequences. HMGB-1 has been recently recognized as a critical mediator of
      inflammatory diseases. In fact, the passive release of this protein from necrotic or damaged
      cells represents an effective stimulus triggering the inflammatory response. Specifically,
      HMGB-1 binds to the receptor for advanced glycation end products (RAGE) and, in turns, it
      activates mitogen-activated protein-kinase (MAPK) and nuclear factor-κB (NF-κB).

      This intracellular pathway leads to the production of several pro-inflammatory cytokines.
      Interestingly, increased levels of HMGB-1 have been observed in atherosclerotic lesions,
      suggesting that HMGB-1 might be involved in the pathophysiology of atherosclerosis.

      This study was designed to investigate the relationship between HMGB-1 and strong
      postinfarction predictors of outcome such as cardiopulmonary and echocardiographic parameters
      before and after a 6-month exercise-based Cardiac Rehabilitation program.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months</measure>
    <time_frame>baseline and 6-month follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months</measure>
    <time_frame>Baseline and 6-month follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Training Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Postinfarction patients undergo 6-month exercise-based Cardiac Rehabilitation Program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Postinfarction patients NOT undergoing 6-months exercise-based Cardiac Rehabilitation program</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise-based Cardiac Rehabilitation program</intervention_name>
    <description>Trained patients attend the exercise training protocol for 6 months on hospital ambulatory-based regimen 3 times/week. Training sessions are supervised under continuous electrocardiography monitoring by a cardiologist, a physiotherapist and a graduate nurse. Each session is preceded by a 5-min warming-up and followed by a 5-min cooling-down. Exercise is performed for 30 min on a bicycle ergometer with the target of 60-70% of the peak oxygen consumption achieved at the initial symptom-limited cardiopulmonary exercise test. Exercise protocol is performed with a gradual increase in exercise workload until the achievement of the predefined target.</description>
    <arm_group_label>Training Group</arm_group_label>
    <other_name>Cardiac Rehabilitation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute Myocardial Infarction

        Exclusion Criteria:

          -  BMI higher than 30 and lower than 18

          -  Residual myocardial ischemia

          -  Severe ventricular arrhythmias

          -  IIb or III degree atrio-ventricular block

          -  Valvular disease requiring surgery

          -  Pericarditis

          -  Severe renal dysfunction (i.e. creatinine &gt;2.5 mg/dl)

          -  Severe concomitant non-cardiac disease such as cancer

          -  Liver dysfunction (alanine aminotransferase/aspartate aminotransferase level &gt;1.5
             times the upper normal limit)

          -  Dementia

          -  Any systemic disease limiting exercise

          -  Inability to participate in a prospective study for any logistic reason
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlo Vigorito, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Federico II University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Naples &quot;Federico II&quot;</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, Moschella S, Psaroudaki M, Del Forno D, Orio F, Vitale DF, Chiariello M, Vigorito C. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. Eur J Cardiovasc Prev Rehabil. 2008 Feb;15(1):113-8. doi: 10.1097/HJR.0b013e3282f00990.</citation>
    <PMID>18277196</PMID>
  </reference>
  <reference>
    <citation>Giallauria F, Galizia G, Lucci R, D'Agostino M, Vitelli A, Maresca L, Orio F, Vigorito C. Favourable effects of exercise-based Cardiac Rehabilitation after acute myocardial infarction on left atrial remodeling. Int J Cardiol. 2009 Aug 21;136(3):300-6. doi: 10.1016/j.ijcard.2008.05.026. Epub 2008 Aug 3.</citation>
    <PMID>18676038</PMID>
  </reference>
  <reference>
    <citation>Giallauria F, De Lorenzo A, Pilerci F, Manakos A, Lucci R, Psaroudaki M, D'Agostino M, Del Forno D, Vigorito C. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):625-32.</citation>
    <PMID>16874155</PMID>
  </reference>
  <reference>
    <citation>Giallauria F, De Lorenzo A, Pilerci F, Manakos A, Lucci R, Psaroudaki M, D'Agostino M, Del Forno D, Vigorito C. Long-term effects of cardiac rehabilitation on end-exercise heart rate recovery after myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):544-50.</citation>
    <PMID>16874143</PMID>
  </reference>
  <reference>
    <citation>Giallauria F, Lucci R, Pietrosante M, Gargiulo G, De Lorenzo A, D'Agostino M, Gerundo G, Abete P, Rengo F, Vigorito C. Exercise-based cardiac rehabilitation improves heart rate recovery in elderly patients after acute myocardial infarction. J Gerontol A Biol Sci Med Sci. 2006 Jul;61(7):713-7.</citation>
    <PMID>16870634</PMID>
  </reference>
  <reference>
    <citation>Cirillo P, Golino P, Calabrò P, Calì G, Ragni M, De Rosa S, Cimmino G, Pacileo M, De Palma R, Forte L, Gargiulo A, Corigliano FG, Angri V, Spagnuolo R, Nitsch L, Chiariello M. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res. 2005 Oct 1;68(1):47-55.</citation>
    <PMID>16023093</PMID>
  </reference>
  <reference>
    <citation>Cirillo P, Calì G, Golino P, Calabrò P, Forte L, De Rosa S, Pacileo M, Ragni M, Scopacasa F, Nitsch L, Chiariello M. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation. 2004 Jun 15;109(23):2911-6. Epub 2004 Jun 1.</citation>
    <PMID>15173027</PMID>
  </reference>
  <reference>
    <citation>Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 Mar 5;105(9):1135-43. Review.</citation>
    <PMID>11877368</PMID>
  </reference>
  <reference>
    <citation>Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine. Clin Chim Acta. 2007 Jan;375(1-2):36-42. Epub 2006 Jul 25. Review.</citation>
    <PMID>16979611</PMID>
  </reference>
  <reference>
    <citation>Giallauria F, Cirillo P, Lucci R, Pacileo M, D'Agostino M, Maietta P, Vitelli A, Chiariello M, Vigorito C. Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction. Atherosclerosis. 2010 Jan;208(1):280-4. doi: 10.1016/j.atherosclerosis.2009.07.025. Epub 2009 Jul 14.</citation>
    <PMID>19651408</PMID>
  </reference>
  <reference>
    <citation>Giallauria F, Cirillo P, Lucci R, Pacileo M, D'agostino M, Maietta P, Vitelli A, Chiariello M, Vigorito C. Effects of exercise-based cardiac rehabilitation on high mobility group box-1 levels after acute myocardial infarction: rationale and design. J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):659-63. doi: 10.2459/JCM.0b013e32832d4979.</citation>
    <PMID>19451831</PMID>
  </reference>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2008</study_first_submitted>
  <study_first_submitted_qc>September 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2008</study_first_posted>
  <results_first_submitted>November 5, 2009</results_first_submitted>
  <results_first_submitted_qc>December 18, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 25, 2010</results_first_posted>
  <last_update_submitted>January 25, 2010</last_update_submitted>
  <last_update_submitted_qc>January 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Carlo Vigorito</name_title>
    <organization>Department of Clinical Medicine, Cardiovascular and Immunological Sciences</organization>
  </responsible_party>
  <keyword>Cardiac Rehabilitation</keyword>
  <keyword>High Mobility Group Box proteins</keyword>
  <keyword>Inflammatory markers</keyword>
  <keyword>Cardiopulmonary Functional Capacity</keyword>
  <keyword>Maximal Oxygen Consumption</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Left Ventricular Ejection Fraction</keyword>
  <keyword>Left Ventricular Chambers Dilation</keyword>
  <keyword>Left Ventricular Remodeling</keyword>
  <keyword>Left Atrium Remodeling</keyword>
  <keyword>Cardiac Remodeling</keyword>
  <keyword>Exercise Training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This study was a single-center, randomized, controlled study carried out from October 2008 to January 2009 at the Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University of Naples “Federico II”.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Exercise Training Group</title>
          <description>Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Exercise Training Group</title>
          <description>Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.8" spread="7.0"/>
                    <measurement group_id="B2" value="59.5" spread="7.7"/>
                    <measurement group_id="B3" value="60.4" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months</title>
        <description>High mobility group box-1 (HMGB1) is a ubiquitous nuclear protein, constitutively expressed in quiescent cells, where it is involved in several cellular functions, including determination of nucleosomal structure and stability, and binding of transcription factors to DNA sequences. HMGB1 has been recently recognized as a critical mediator of inflammatory processes: the passive release of this protein from necrotic or damaged cells represents an effective stimulus triggering the inflammatory response.</description>
        <time_frame>baseline and 6-month follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Training Group</title>
            <description>Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.</description>
          </group>
        </group_list>
        <measure>
          <title>High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months</title>
          <description>High mobility group box-1 (HMGB1) is a ubiquitous nuclear protein, constitutively expressed in quiescent cells, where it is involved in several cellular functions, including determination of nucleosomal structure and stability, and binding of transcription factors to DNA sequences. HMGB1 has been recently recognized as a critical mediator of inflammatory processes: the passive release of this protein from necrotic or damaged cells represents an effective stimulus triggering the inflammatory response.</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.6" spread="27.8"/>
                    <measurement group_id="O2" value="24.5" spread="18.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.7" spread="7.0"/>
                    <measurement group_id="O2" value="20.5" spread="15.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Sample size determination was based on a t-test assuming a normal distribution with non-equal variance with the mean and standard deviation for the experimental group (postinfarction patients) of HMGB1 levels equal to 15 ± 7 and 2 ± 1 ng/dl for the control group derived from a previous study, respectively. The required sample size was calculated to be 30 subjects per group to detect on the size of one SD with α value of 0.05 (two-sided) and power (1 – β) of 0.8.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months</title>
        <description>Oxygen consumption at peak exercise stress testing (VO2peak) was obtained breath-by-breath with use of a computerized metabolic cart. VO2peak was recorded as the mean value of VO2 during the last 20 s of the test and expressed in millilitres per kilogram per minute.</description>
        <time_frame>Baseline and 6-month follow-up</time_frame>
        <population>intention to treat (ITT) analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Exercise Training Group</title>
            <description>Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months</title>
          <description>Oxygen consumption at peak exercise stress testing (VO2peak) was obtained breath-by-breath with use of a computerized metabolic cart. VO2peak was recorded as the mean value of VO2 during the last 20 s of the test and expressed in millilitres per kilogram per minute.</description>
          <population>intention to treat (ITT) analysis</population>
          <units>ml/kg/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.4" spread="1.5"/>
                    <measurement group_id="O2" value="16.7" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.0" spread="2.4"/>
                    <measurement group_id="O2" value="16.3" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Heart Rate Recovery at Baseline and 6 Months</title>
        <description>The autonomic nervous system (ANS) is the part of the peripheral nervous system that acts as a control system functioning largely below the level of consciousness, and controls visceral functions. It is subdivided into two subsystems: the parasympathetic (vagal) and sympathetic nervous system.
Sympatho-vagal imbalance is evaluated by post-exercise Heart Rate Recovery (HRR), defined as the fall in heart rate during the first minute after exercise (beats/min). HRR is a marker of vagal tone which is a powerful predictor of all-cause mortality in patients with coronary artery disease.</description>
        <time_frame>baseline and 6 month follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Training Group</title>
            <description>Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate Recovery at Baseline and 6 Months</title>
          <description>The autonomic nervous system (ANS) is the part of the peripheral nervous system that acts as a control system functioning largely below the level of consciousness, and controls visceral functions. It is subdivided into two subsystems: the parasympathetic (vagal) and sympathetic nervous system.
Sympatho-vagal imbalance is evaluated by post-exercise Heart Rate Recovery (HRR), defined as the fall in heart rate during the first minute after exercise (beats/min). HRR is a marker of vagal tone which is a powerful predictor of all-cause mortality in patients with coronary artery disease.</description>
          <units>beats/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.4" spread="1.7"/>
                    <measurement group_id="O2" value="13.8" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.7" spread="3.4"/>
                    <measurement group_id="O2" value="12.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Exercise Training Group</title>
          <description>Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University</name_or_title>
      <organization>University of Naples Federico II</organization>
      <phone>+39081746 ext 2639</phone>
      <email>vigorito@unina.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

